Medtronic PLC (MDT) Shares Bought by Bluestein R H & Co.

Bluestein R H & Co. lifted its stake in Medtronic PLC (NYSE:MDT) by 6.3% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 318,231 shares of the medical technology company’s stock after acquiring an additional 18,764 shares during the period. Medtronic PLC accounts for approximately 1.6% of Bluestein R H & Co.’s holdings, making the stock its 29th biggest position. Bluestein R H & Co.’s holdings in Medtronic PLC were worth $28,243,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of the company. Hudock Capital Group LLC lifted its stake in shares of Medtronic PLC by 0.5% in the 2nd quarter. Hudock Capital Group LLC now owns 2,195 shares of the medical technology company’s stock worth $194,000 after acquiring an additional 11 shares during the period. Bollard Group LLC lifted its stake in shares of Medtronic PLC by 0.4% in the 2nd quarter. Bollard Group LLC now owns 3,651 shares of the medical technology company’s stock worth $324,000 after acquiring an additional 14 shares during the period. Triangle Securities Wealth Management lifted its stake in shares of Medtronic PLC by 0.3% in the 2nd quarter. Triangle Securities Wealth Management now owns 4,396 shares of the medical technology company’s stock worth $390,000 after acquiring an additional 15 shares during the period. IFC Holdings Incorporated FL lifted its stake in shares of Medtronic PLC by 0.3% in the 2nd quarter. IFC Holdings Incorporated FL now owns 5,673 shares of the medical technology company’s stock worth $501,000 after acquiring an additional 17 shares during the period. Finally, North Star Investment Management Corp. lifted its stake in shares of Medtronic PLC by 1.1% in the 2nd quarter. North Star Investment Management Corp. now owns 1,995 shares of the medical technology company’s stock worth $177,000 after acquiring an additional 22 shares during the period. 80.91% of the stock is owned by institutional investors.

Medtronic PLC (NYSE:MDT) opened at $79.33 on Friday. The firm has a market cap of $107,459.70, a P/E ratio of 16.91, a price-to-earnings-growth ratio of 2.20 and a beta of 1.00. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.64 and a quick ratio of 1.40. Medtronic PLC has a 12 month low of $69.35 and a 12 month high of $89.72.

Medtronic PLC (NYSE:MDT) last released its quarterly earnings data on Tuesday, August 22nd. The medical technology company reported $1.12 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.08 by $0.04. The firm had revenue of $7.39 billion for the quarter, compared to analyst estimates of $7.44 billion. Medtronic PLC had a net margin of 13.75% and a return on equity of 12.92%. The company’s revenue for the quarter was up 3.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.03 EPS. equities research analysts expect that Medtronic PLC will post 4.66 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 20th. Shareholders of record on Friday, September 29th were paid a $0.46 dividend. The ex-dividend date was Thursday, September 28th. This represents a $1.84 annualized dividend and a yield of 2.32%. Medtronic PLC’s dividend payout ratio is presently 61.95%.

A number of brokerages have recently weighed in on MDT. Jefferies Group LLC reaffirmed a “buy” rating and issued a $96.00 price target on shares of Medtronic PLC in a research note on Thursday, September 28th. SunTrust Banks, Inc. reaffirmed a “buy” rating and issued a $96.00 price target on shares of Medtronic PLC in a research note on Monday, October 2nd. Zacks Investment Research lowered shares of Medtronic PLC from a “hold” rating to a “sell” rating in a research note on Friday, August 25th. BidaskClub lowered shares of Medtronic PLC from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 24th. Finally, Cowen and Company set a $95.00 target price on shares of Medtronic PLC and gave the company a “buy” rating in a research note on Tuesday, August 22nd. Three research analysts have rated the stock with a sell rating, ten have issued a hold rating and thirteen have assigned a buy rating to the company. Medtronic PLC presently has an average rating of “Hold” and an average target price of $87.88.

COPYRIGHT VIOLATION WARNING: “Medtronic PLC (MDT) Shares Bought by Bluestein R H & Co.” was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of United States and international trademark and copyright legislation. The original version of this story can be accessed at https://www.dispatchtribunal.com/2017/11/12/medtronic-plc-mdt-shares-bought-by-bluestein-r-h-co.html.

In other Medtronic PLC news, EVP Bryan C. Hanson sold 16,000 shares of the company’s stock in a transaction that occurred on Monday, October 16th. The shares were sold at an average price of $78.03, for a total value of $1,248,480.00. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CEO Omar Ishrak sold 140,407 shares of the company’s stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $81.63, for a total transaction of $11,461,423.41. Following the completion of the transaction, the chief executive officer now owns 668,503 shares in the company, valued at approximately $54,569,899.89. The disclosure for this sale can be found here. 0.31% of the stock is currently owned by corporate insiders.

About Medtronic PLC

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.

Want to see what other hedge funds are holding MDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic PLC (NYSE:MDT).

Institutional Ownership by Quarter for Medtronic PLC (NYSE:MDT)

Receive News & Ratings for Medtronic PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic PLC and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply